TOKYO (Reuters) - U.S. private equity firm Bain Capital said it may withdraw its tender offer proposal for Japanese IT firm ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

SelectQuote (SLQT) announced that the company signed a $350M strategic investment from funds managed by Bain Capital, Morgan Stanley Private ...

Bain Capital is considering withdrawing its tender offer for Japanese IT firm Fuji Soft after rival U.S. private equity giant ...

Under the nonbinding proposal, Bain Capital Private Equity would acquire the remaining shares of Surgery Partners it does not ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

In a statement, Bain said that it is 'carefully considering' its future policy, including 'the option of withdrawing' its ...

In a notable performance, Bain Capital Specialty Finance (NYSE:BCSF) stock has reached a 52-week high, touching $17.27. This peak reflects a significant uptrend for the company,... Bain Capital ...

Bain Capital will partner with Milacron’s current owner ... or results of the Proposed Transaction on the market price of the Hillenbrand’s common stock; and risks related to diversion of management’s ...

Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.